IvyRock Asset Management »

Arrivent Biopharma shares owned by IvyRock Asset Management

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by IvyRock Asset Management from 13F filings

Historical chart of IvyRock Asset Management investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by IvyRock Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by IvyRock Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $369k 16k 23.07

More positions owned by IvyRock Asset Management

Pdd Holdings Sponsored Ads (PDD)
Legend Biotech Corp- Sponsored Ads (LEGN)
Alibaba Group Holding-sp Sponsored Ads (BABA)
Circle Internet Group Com Cl A (CRCL)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ke Holdings Inc- Sponsored Ads (BEKE)
Tesla Motors (TSLA)
Huya Inc- Ads Rep Shs A (HUYA)
Spdr Gold Shares Spdr Gold Tr (GLD)
Arrowhead Pharmaceuticals (ARWR)
Sprott Uranium Miners Etf Uranium Miners E (URNM)
Global X Copper Miners Etf Global X Copper (COPX)
Microsoft Corporation (MSFT)
Arrivent Biopharma (AVBP)
Cisco Systems (CSCO)

View all positions for IvyRock Asset Management

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
FMR
OrbiMed Advisors
BlackRock
Octagon Capital Advisors
Novo A/S
Vanguard Group
Sofinnova Ventures
Vanguard Capital Management
General Catalyst Group Management
State Street Corporation
Vivo Capital
Goldman Sachs Group

View all funds holding Arrivent Biopharma